Filament’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$2.22M Sell
15,016
-20
-0.1% -$3.1K 0.6% 18
2020
Q2
$2.47M Hold
15,036
0.8% 16
2020
Q1
$2.08M Buy
15,036
+9
+0.1% +$1.24K 0.78% 17
2019
Q4
$1.97M Sell
15,027
-86
-0.6% -$9.97K 0.6% 18
2019
Q3
$1.69M Sell
15,113
-4,903
-24% -$546K 0.56% 19
2019
Q2
$2.22M Hold
20,016
0.7% 17
2019
Q1
$2.6M Hold
20,016
0.86% 17
2018
Q4
$2.32M Sell
20,016
-1,136
-5% -$127K 0.86% 16
2018
Q3
$2.27M Hold
21,152
0.77% 14
2018
Q2
$1.8M Sell
21,152
-3,012
-12% -$247K 0.62% 16
2018
Q1
$1.87M Hold
24,164
0.67% 16
2017
Q4
$2.04M Sell
24,164
-2,953
-11% -$251K 0.76% 16
2017
Q3
$2.32M Buy
27,117
+7
+0% +$574 0.89% 14
2017
Q2
$2.23M Hold
27,110
0.89% 12
2017
Q1
$2.28M Hold
27,110
1.01% 12
2016
Q4
$1.99M Hold
27,110
0.94% 13
2016
Q3
$2.18M Sell
27,110
-5,390
-17% -$431K 1.01% 12
2016
Q2
$2.56M Sell
32,500
-1,320
-4% -$99.4K 1.24% 10
2016
Q1
$2.44M Hold
33,820
1.15% 10
2015
Q4
$2.85M Sell
33,820
-31
-0.1% -$2.57K 1.38% 11
2015
Q3
$2.83M Sell
33,851
-25
-0.1% -$2.11K 1.5% 9
2015
Q2
$2.83M Sell
33,876
-29
-0.1% -$2.21K 1.31% 10
2015
Q1
$2.46M Hold
33,905
1.11% 11
2014
Q4
$2.34M Hold
33,905
1.08% 11
2014
Q3
$2.2M Buy
33,905
+25
+0.1% +$1.58K 1.01% 12
2014
Q2
$2.11M Hold
33,880
0.9% 14
2014
Q1
$1.99M Hold
33,880
0.93% 13
2013
Q4
$1.73M Hold
33,880
0.83% 13
2013
Q3
$1.71M Hold
33,880
0.87% 13
2013
Q2
$1.66M Buy
+33,880
New +$1.84M 0.92% 13

Other funds holding LLY

Filament's LLY Position: Q3 2020 in Review

Filament reduced its Eli Lilly (LLY) stake by 0.13% in Q3 2020, selling an estimated $3.1K and leaving 15,016 shares worth $2.22M. The position accounts for 0.6% of the portfolio, ranked #18.

Filament first reported a position in LLY in Q2 2013 and has held it in 30 quarters since. The position peaked at $2.85M in Q4 2015. 1,773 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • Filament held 15,016 shares of Eli Lilly worth $2.22M as of Q3 2020.
  • Filament sold 20 Eli Lilly shares in Q3 2020, an estimated $3.1K.
  • Eli Lilly made up 0.6% of Filament's portfolio in Q3 2020, its #18 holding.
  • Filament first reported a position in Eli Lilly in Q2 2013 and has held it in 30 quarters since.
  • Filament's Eli Lilly position peaked at $2.85M in Q4 2015.
  • 1,773 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Filament's 13F filing for Q3 2020, filed 5 Nov 2020.